| |
| |
EpiGenX is pursuing the development of novel therapeutics
to treat cancer and infectious disease. The company's approach
brings together expertise in identifying potential new "targets"
(key cellular components that cause disease) and the ability
to identify and develop lead compounds that modulate these targets.
NewMarque provides EpiGenX with a full spectrum of brand development
services; from analysis to implementation. In addition to consulting
services, we created the company's brand identity, tradeshow
displays, signage, PowerPoint presentations, web site. We also
write press releases and create marketing collateral as a component
of the company's outward expression of its brand identity.
|
|
|
|
